Merck (MRK) Divestments (2009 - 2021)

Merck (MRK) posted quarterly Divestments of -$82.0 million for Q2 2021, down 57.69% quarter-over-quarter from -$52.0 million in Q1 2021.

Merck (MRK) Divestments (2009 - 2021) Analysis & Trends

Merck (MRK) has reported Divestments for 7 consecutive years, with -$82.0 million the latest figure, recorded in Q2 2021.

In Q2 2021, Divestments changed N/A year-over-year to -$82.0 million; the TTM figure through Mar 2022 stood at -$82.0 million (up 59.41% YoY), while the FY2021 annual figure was -$134.0 million, up 46.4% from the prior year.
Divestments retreated to -$82.0 million in Q2 2021 per MRK's latest filing, from -$52.0 million in the prior quarter.
Across five years, Divestments topped out at -$52.0 million in Q1 2021 and bottomed at -$82.0 million in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Johnson & Johnson	653.97 Bn	633.21 Bn	17.26 Bn	-
2	AbbVie	470.43 Bn	463.86 Bn	12.70 Bn	-
3	Merck	376.87 Bn	369.73 Bn	12.21 Bn	-
4	Novartis Ag	303.36 Bn	295.67 Bn	11.24 Bn	62.00 Mn
5	Astrazeneca	257.56 Bn	252.66 Bn	12.86 Bn	-
6	Amgen	236.76 Bn	222.77 Bn	7.24 Bn	-
7	Gilead Sciences	182.01 Bn	178.83 Bn	6.22 Bn	-
8	Pfizer	159.37 Bn	147.67 Bn	10.94 Bn	1.88 Bn
9	Gsk	106.08 Bn	101.91 Bn	8.24 Bn	-
10	Sanofi	55.09 Bn	47.71 Bn	10.79 Bn	-

Download Data